Cart
sales@molnova.com
PF-04929113 Mesylate
CAS No. 1173111-67-5
PF-04929113 Mesylate( SNX-5422 Mesylate | PF04929113 Mesylate | SNX5422 Mesylate )
Catalog No. M10581 CAS No. 1173111-67-5
The prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 92 | Get Quote |
|
| 5MG | 146 | Get Quote |
|
| 10MG | 273 | Get Quote |
|
| 25MG | 396 | Get Quote |
|
| 50MG | 583 | Get Quote |
|
| 100MG | 833 | Get Quote |
|
| 500MG | 1683 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-04929113 Mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor.
-
DescriptionThe prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor; inhibits several signaling pathways and induces apoptosis in CRPC LNCaP tumors in vivo.Blood Cancer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsSNX-5422 Mesylate | PF04929113 Mesylate | SNX5422 Mesylate
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP90|HER2
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1173111-67-5
-
Formula Weight617.6377
-
Molecular FormulaC26H34F3N5O7S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)OC(=O)CN)C(F)(F)F)C.CS(=O)(=O)O
-
Chemical NameGlycine, trans-4-[[2-(aminocarbonyl)-5-[4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl]phenyl]amino]cyclohexyl ester, methanesulfonate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lamoureux F, et al. Clin Cancer Res. 2011 Jul 15;17(14):4916.
2. Rajan A, et al. Clin Cancer Res. 2011 Nov 1;17(21):6831-9.
molnova catalog
related products
-
PU-H71 HCl
PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT.
-
PU-WS13
A potent and selective Grp94 inhibitor with Ic50 of 0.22 uM.
-
STA 2842
STA 2842 (STA2842) is a highly specific inhibitor of HSP90 (IC50=135 nM, HSP90α) that competitively binds the N-terminal ATP pocket of HSP90.
